Henry Welle

PHD Doctor of Philosophy,  CharitĂ© - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Journal Manuscript Biostatistics IT-Web-Mobile Technology Admin and Customer Support

Areas Of Interest

Pertechnetate, Technetium Sarsaparillas Root Cysts, Dental Cellular Plasticity Phospholipase A2, Group IIE Gel Electrophoresis, Pulsed Field Chinaberry Tree Long-Tusked Marmosets Insurances, Psychiatric Hallucinogenic Agents Real-Time System Augmentations, Alveolar Ridge Biliary Stasis, Intrahepatic Plants, Power Endonuclease SolI Tongue Piercings Interleukin 12 Subunit p35 Ureterolithiasis Health Services for Aged LEAR Oil Cone Rod Dystrophy 2 Stereotaxy, Frameless Counselings, Sex

Professional Narrative

Dr. Henry Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2008
Assistant Professor, Harvard Med 1987

Education

Bachelor of science in nursing, Perelman School of Medicine 1993
Doctor of osteopathic medicine, Perelman School of Medicine 1990

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :